UNLIMITED FREE ACCESS TO THE WORLD'S BEST IDEAS

close
Already an Engineering360 user? Log in.

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

Customize Your Engineering360 Experience

close
Privacy Policy

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

CLSI EP37

Supplemental Tables for Interference Testing in Clinical Chemistry

active, Most Current
Buy Now
Organization: CLSI
Publication Date: 1 April 2018
Status: active
Page Count: 112
scope:

The supplemental tables presented in this document are intended for use with the evaluation procedures presented in CLSI document EP07-Interference Testing in Clinical Chemistry. EP07 describes protocols for manufacturers of in vitro diagnostic measurement procedures to screen potentially interfering substances, quantify interference effects, and confirm interference in patient samples. It also describes procedures for medical laboratories to verify interference claims and investigate discrepant results caused by unsuspected interfering substances. The supplemental tables in EP37 provide recommended test concentrations for analytes and endogenous substances that may interfere in clinical chemistry measurement procedures.

Clinical and Laboratory Standards Institute (CLSI). Supplemental Tables for Interference Testing in Clinical Chemistry. 1st ed. CLSI supplement EP37 (ISBN 1-56238-848-7). Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087 USA, 2018.

Document History

CLSI EP37
April 1, 2018
Supplemental Tables for Interference Testing in Clinical Chemistry
The supplemental tables presented in this document are intended for use with the evaluation procedures presented in CLSI document EP07—Interference Testing in Clinical Chemistry. EP07 describes...

References

Advertisement